GBA Presents: House of Gummy-!

Vz this Greek food IPO looks tasty-

Why it matters: U.S. IPOs have been few and far between since the beginning of last year, so the entire market will pay close attention to Cava's performance.

  • Were it to price and trade strong, this could rekindle interest from companies beyond the restaurant sector.
Details: Cava disclosed that it's offering 14.44 million shares at between $17 and $19 per share. Were it to price at the top, its market value would be just north of $2.1 billion.

  • The Washington, D.C.-based company plans to list on the New York Stock Exchange under ticker symbol CAVA.
  • It had raised venture capital funding from firms like T. Rowe Price, SWaN & Legend and Revolution Group.
  • Revenue climbed 12.8% last year to around $564 million, while its losses expanded to nearly $59 million.
  • In 2018 the company bought rival Zoe's Kitchen for around $300 million.
The bottom line, per Axios' Kimberly Chin: "There are cracks in the quick-serve restaurant sector due to pressured margins and hot competition, but Cava is increasing its top line and cutting losses, both of which are must-haves for public market investors."
 
Vz this Greek food IPO looks tasty-

Why it matters: U.S. IPOs have been few and far between since the beginning of last year, so the entire market will pay close attention to Cava's performance.

  • Were it to price and trade strong, this could rekindle interest from companies beyond the restaurant sector.
Details: Cava disclosed that it's offering 14.44 million shares at between $17 and $19 per share. Were it to price at the top, its market value would be just north of $2.1 billion.

  • The Washington, D.C.-based company plans to list on the New York Stock Exchange under ticker symbol CAVA.
  • It had raised venture capital funding from firms like T. Rowe Price, SWaN & Legend and Revolution Group.
  • Revenue climbed 12.8% last year to around $564 million, while its losses expanded to nearly $59 million.
  • In 2018 the company bought rival Zoe's Kitchen for around $300 million.
The bottom line, per Axios' Kimberly Chin: "There are cracks in the quick-serve restaurant sector due to pressured margins and hot competition, but Cava is increasing its top line and cutting losses, both of which are must-haves for public market investors."
I looked at their website Stoney, they have a lot of locations. I think there's one by you. Without trying it first, I'd let the dust settle on the IPO before I'd buy in. There is one in Orlando..... so maybe we can get @Baron to give us one of his Diners, Drive-Ins, and Dives videos like he did for Portillos. That saved me from losing money on your "buy at $22" call. :mad:

21st and 6th

678 6th Avenue New York, NY 10010

307 7th Ave

307 7th Avenue New York, NY 10001

38th and Broadway

1385 Broadway New York, NY 10018

40th and Madison

280 Madison Ave New York, NY 10016

708 3rd Ave

708 3rd Ave New York, NY 10017

Bryant Park

11 W 42nd Street New York, NY 10036

Downtown Brooklyn

345 Adams Street Brooklyn, NY 11201

Melville

880 Walt Whitman Road Space F 876 Melville, NY 11747

Nolita

50 Spring Street New York, NY 10012

Park Ave South

325 Park Avenue South New York, NY 10010

Rye Ridge

3 Rye Ridge Plaza Rye Brook, NY 10573

Union Square

143 4th Avenue New York, NY 10003

Wall Street <<<<---Stoney is probably banned

63 Wall Street New York, NY 10005
 
Last edited:
Wow how have I not see these: Union Square I live right nearby and 21st and 6th--

I can do this!! I will sample their offerings next week. And then buy the IPO.

 
COYA +2.55% <------- :thumbsup:



I have some bad news which may be good news. A super huge drug co has made a move on Tregs.

They have chosen some other biotech I have never heard of.

But could that shine alight on the process and validate us in a way....

I think so.

Could it attract a partnership our way, the Coya way..

I hope so

Will we blast off today?

We better.
 
--Repare Therapeutics price target raised to $26 from $25 at H.C. Wainwright 06:26 RPTX

--Archer Aviation initiated with a Buy at Canaccord » 05:23 ACHR

--Vision Marine Technologies initiated with a Buy at Roth MKM 05:01 VMAR

--Corning upgraded to Overweight from Equal Weight at Morgan Stanley » 05:00 GLW

--Erasca CEO buys $275K in common stock » 21:08 ERAS

--Morgan Stanley questions if Fisker can 'do a Lucid' and raise capital 13:36 FSR, LCID

--BlackRock seeks $7B for new Global Renewable Power Fund, Reuters reports » 12:10 BLK
 
These guys report on June 8th.-

There was drought and fires to worry about /// Do any of these brands speak to you?

The chart has popped up in my TA screens the last week.-

About The Duckhorn Portfolio, Inc.

The Duckhorn Portfolio is North America’s premier luxury wine company, with ten wineries, eight state-of-the-art winemaking facilities, seven tasting rooms and over 1,100 coveted acres of vineyards spanning 32 Estate properties. Established in 1976, when vintners Dan and Margaret Duckhorn founded Napa Valley’s Duckhorn Vineyards, today, our portfolio features some of North America’s most revered wineries, including Duckhorn Vineyards, Decoy, Paraduxx, Goldeneye, Migration, Canvasback, Calera, Kosta Browne, Greenwing and Postmark. Sourcing grapes from our own Estate vineyards and fine growers in Napa Valley, Sonoma County, Anderson Valley, California’s North and Central coasts, and Washington State, we offer a curated and comprehensive portfolio of acclaimed luxury wines with price points ranging from $20 to $200 across more than 15 varietals and 31 appellations. Our wines are available throughout the United States, on five continents, and in more than 50 countries around the world.




Ka-POW!!!! stoney on fire!!!!!!!!!! 8th Winner in a row is he going for th record 44...... NO!!!!!!

Duckorn Portfolio raises FY23 EPS view to 64c-66c from 63c-65c, consensus 64c » 16:08 NAPA Raises FY23 revenue view… Duckhorn Portfolio reports Q3 adjusted EPS 16c, consensus 12c » 16:07 NAPA Reports Q3 revenue…

:):):):):):):):):):)
 
Back In March---

Duckhorn Portfolio upgraded to Overweight at Barclays after pullback 03/09 NAPA Barclays upgraded Duckhorn Portfolio to Overweight from Equal Weight with a $17 price target. While the firm has "felt good about the fundamentals" since it initiated coverage in April 2021 following the company's IPO, the stock's "rich valuation" compared to alcohol peers had previously kept it on the sidelines. However, the stock declined nearly 30% in 2022 and shares are down another 9.5% year-to-date even though "the quality business performance is still very much intact," the analyst tells investors. Barclays now sees the risk-reward proposition skewing to the upside from current levels given its view that Duckhorn's roughly 11% calendar 2023 organic sales growth and 12% EPS growth view "could well prove conservative."





$13.830.15(+1.10%)4:00 PM 06/08/23
NYSE |$USD |Pre-Market:$14.51+0.68(+4.92%)<----- should be more! :mad:7:10 AM
 
Modelo Especial is a pilsner-style lager that began nearly 100 years ago in Mexico. Constellation Brands bought Modelo from ABI in 2013. Since then, Constellation has prioritized sales of Modelo, specifically by making sure stores never run out of stock, Williams said.

Constellation also plans to increase the brand's sales by introducing "Modelo to new consumers through increased distribution and presence at retail," spokesperson Stephanie McGuane told CBS MoneyWatch on Thursday.
 
Back
Top